Deenen, Maarten J <br/><br/>
Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.  [electronic resource] 

 -  The oncologist  2011 
 - 820-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2010-0259  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Antineoplastic Agents--adverse effects<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Biomarkers<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--metabolism<br/>Genotype<br/>Humans<br/>Neoplasm Proteins--genetics<br/>Pharmacogenetics--methods<br/>Polymorphism, Single Nucleotide<br/>Precision Medicine<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome